Amy Simon Beam Therapeutics Inc. (BEAM) insider trading activity
Amy Simon is Chief Medical Officer of Beam Therapeutics Inc.. Currently has a direct ownership of 68,805 shares of BEAM, which is worth approximately $1.69 Million. The most recent transaction as insider was on Jul 02, 2024, when has been sold 748 shares (Common Stock) at a price of $22.95 per share, resulting in proceeds of $17,166. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
68.8K
0%
3M change
5.1%
12M change
Total Value Held
$1.69 Million
Amy Simon Transaction History
AS
Amy Simon
Chief Medical Officer
Cambridge, MA